Recent studies have reported reduced endocrine and symptomatic responses to hypoglycaemia 18-24 h after antecedent hypoglycaemia in both non-diabetic subjects and those with insulin-dependent diabetes mellitus. We examined these and peripheral physiological responses in eight nondiabetic subjects aged 23-35 years in the week following antecedent hypoglycaemia. Blood glucose levels were held at plateaus of 5 mmol/1 and 2.5 mmol/1 for 30 min during hyperinsulinaemic (60 mU-m -2. min -~) morning clamps on days 1, 3 and 8 of two study periods separated by at least 4 weeks. Measurements were made at time 0, 15 and 30 min of each plateau on each day. On the afternoon of Day 1 we also induced either euglycaemia with a blood glucose level of 5 mmol/1 (control week) or hypoglycaemia of 2.9 mmol/1 (hypo week) for 2 h in random order. The adrenaline response to morning hypoglycaemia (p < 0.01 on all days) was attenuated on Day3 (p < 0.05) and Day 8 (p < 0.05) compared to Day i of hypo week only. Sweating was also attenuated on Day 3 (p < 0.05) and Day 8 (p < 0.02) of hypo week only. Noradrenaline levels and tremor increased during hypoglycaemia on each study day (p < 0.05) but did not differ between days in either week. During hypo week only, the total symptom score response to hypoglycaemia was attenuated on Day 3 (p < 0.03) but not Day 8 (p = 0.10). Autonomic symptoms were similarly affected. In summary, the physiological responses to hypoglycaemia are affected differentially by antecedent hypoglycaemia with sweating and adrenaline responses remaining impaired for at least 5 days. [Diabetologia (1995[Diabetologia ( ) 38: 1183[Diabetologia ( -1190 
The findings of the Diabetes Control and Complications Trial have highlighted not only the benefits but also the risks of tight glycaemic control with severe hypoglycaemic episodes occurring three times more frequently in the intensively treated group [1, 2] . Hypoglycaemia is common due to inappropriate hyper-insulinaemia and acquired impairments in the physiological mechanisms which defend the body against hypoglycaemia [3, 4] . These defences include not only the release of counterregulatory hormones which can restore blood glucose to normal levels [5] but also peripheral physiological responses which produce warning symptoms of impending hypoglycaemia [6] . Loss of hypoglycaemia awareness is associated with a diminished physiological response to hypoglycaemia, particularly that produced by activation of the sympathoadrenal system [7, 8] . Patients who develop unawareness are at particular risk of severe hypoglycaemia especially during intensive insulin therapy [9] .
It is not clear why only some patients develop hypoglycaemia unawareness, although important fac- After an initial 35-rain run-in period, blood glucose was held at 5 mmol/1 for 30 min and then allowed to fall over a further 35-rain period to a level of 2.5 mmol/1. It was held at this level for a fitrther 30 min. Subjects were blinded to their blood glucose level at all times.
A further hyperinsulinaemic clamp (80 mU. m -2. min I) was performed on the afternoon of Day 1 during each study period, with control and hypoglycaemia (HYPO) weeks distinguished by different interventions. On one occasion, we maintained the blood glucose level at 2.9 mmol/1 for 2 h (interval hypo stimulus) and on the other, 5 mmol/1 (interval control stimulus) for the same period. These were performed in random order.
At times 0, 15 and 30 rain of the 5 mmol/1 and 2.5 mmol/1 plateaus during morning experiments, we made the following measurements. Fig. 1 . Diagram of the study design. All morning clamps were at 5 and 2.5 mmol/1 plateaus for 30 min each. Study weeks were at least 4 weeks apart tots include a long disease duration [10] and tight glycaemic control [11, 12] . We have previously shown that a brief period of mild hypoglycaemia causes reduced counterregulatory and symptomatic responses to subsequent hypoglycaemia in normal subjects [13] and this has now been observed after overnight hypoglycaemia [14] and in patients with insulin-dependent diabetes mellitus (IDDM) [15] . This short-term adaptation to antecedent hypoglycaemia may partly explain the association of hypoglycaemia unawareness with intensified insulin therapy [12] , although the duration of adaptation remains unknown. Previous studies have not examined the relationship between hypoglycaemic symptoms and objective measurements of the peripheral physiological response following antecedent hypoglycaemia. Thus, the aim of our study was to measure the effect of antecedent hypoglycaemia on the peripheral physiological, endocrine and symptomatic response to hypoglycaemia after 2 and 7 days.
Subjects and methods
Subjects. Eight non-diabetic subjects (seven male, one female) gave written consent to participate in this study which was approved by the Research ethics committee of the Northern General Hospital Trust, Sheffield, UK. Their mean age was 26 years (range 23-35) with a mean body mass index + SEM of 22.5 _+ 0.5 kg/m ~. They had no family history of diabetes and were using no medication.
Study design. Each subject was studied during two 8-day periods separated by at least 4 weeks (Fig. 1) . After overnight fasting, hyperinsulinaemic hypoglycaemic clamps were performed on the mornings of days 1, 3 and 8 of each study period. Human soluble insulin (Actrapid; Novo Laboratories, Copenhagen, Denmark) was infused at a fixed rate throughout (60 mU. m -2. min -1) through a cannula placed in an antecubital vein of the non-dominant arm. Dextrose (200 g/l) was given into the same vein using an IVAC 591 pump (IVAC, San Diego, Calif., USA). The infusion rate was adjusted at 5-min intervals according to blood glucose measurements obtained from a retrograde cannula inserted into a dorsal hand vein of the same arm, with the hand kept in a heated box at 55 ~ Blood glucose Physiological measurements. Blood pressure and pulse were assessed by means of an Accutorr sphygmomanometer (Datascope Medical Co. Ltd, Huntingdon, Herts., UK) employing an automated oscillatory analysis method with the cuff sited on the dominant arm.
Rates of sweating were measured using a 25-cm 2 ventilated chamber placed on the lower sternum. Flow rate through the chamber was maintained at 1 litre/min. The difference in humidity between the inflowing and outflowing air was measured using a surface resistance humidity sensor (Phys-Chemical Research Corporation, New York, N.Y., USA). Calculation of rate of water loss was based on measurements of humidity and ambient temperature as previously described [16] .
Finger tremor was measured using a ring accelerometer consisting of a bimorph piezo electric element (Radio Spares, Corby, Northants, UK) loaded with a 56-mg weight, The element was mounted horizontally inside a 50 x 10-mm plastic tube attached at one end to a small metal plate. The accelerometer was placed on the index finger of the non-dominant hand and finger tremor measured over a 1-min period with the hand held outstretched and the forearm supported [17] . The signal from the transducer was amplified and filtered (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) Hz bandpass with a 12 decibel/octave roll-off) and the output digitised at a rate of 200 samples/s using an Amplicon PC26AT 12 bit A/D convertor (Amplicon Liveline, Brighton, Sussex, UK) attached to a notebook computer. The tremor signal was displayed on the computer and the root mean square (RMS) voltage of the tremor signal calculated over the 1-min measurement period.
Symptom scores. Symptom scores [18] were obtained by asking subjects to rate a series of individual symptoms from 1 (not present) to 7 (very severe). Symptoms described were: sweating, tremor, palpitations, warmth (autonomic); difficulty speaking, confusion, dizziness (neuroglycopenic); itching (dummy). Symptoms were listed in random order on each sheet used.
Endocrine measurements. A 5-ml sample of blood was added to a lithium-heparin tube containing 0.1 ml of EGTA-glutathione and after separation, the plasma was stored at -80 ~ Plasma adrenaline and noradrenaline were analysed by high performance liquid chromatography with electrochemical detection [19] . Coefficients of variation for the assays were 8 and 4 %, respectively.
A 5-ml sample of blood was added to a plain tube and allowed to clot at room temperature. It was then centrifuged and the plasma stored at -80 ~ Total plasma insulin was measured using a double-antibody RIA method [20] . 
Results
Results are expressed as mean + SEM unless otherwise indicated. The study period in which the afternoon interval stimulus induced on Day 1 was hypoglycaemia is referred to as hypo week. The study period in which the afternoon interval stimulus induced on Day 1 was euglycaemia is designated as the control week.
Glucose and insulin
Glucose values during the afternoon clamps. Mean whole blood glucose concentrations measured at 5-rain intervals over a 2-h period were 4.98 + 0.02 mmol/1 during afternoon euglycaemia and 2.90+ 0.01 during afternoon hypoglycaemia.
Glucose and insulin values during the morning clamps. The mean glucose concentrations achieved
during the 30-min morning hypoglycaemic plateaus were similar on all study days (Fig. 2) .
Steady-state plasma insulin concentrations were similar in all studies during morning euglycaemic and hypoglycaemic plateaus. The concentrations during euglycaemia and hypoglycaemia, respectively in the control week were (in mU/l): Day 1, 120.0 + 5. 
Catecholamines

Statistical analysis
Measurements made at 0, 15 and 30 min at each glucose level were integrated by calculating areas under the curve (AUC) [21] . We calculated the difference in the AUC at 5 and 2.5 mmol/1 for each experimental day and compared results on different days by paired Student's t-test using transformed data (square roots) for non-normal distributions. A p-value of less than 0.05 was regarded as significant.
Adrenaline levels (Tables i and 2 ml-1), the response on Day3 was reduced (43.7 + 5.6 pmol. min -1 9 mP 1, p < 0.05) as was the response on Day 8 (55.5 + 9.7 pmol. min -~ 9 m1-1, p < 0.05).
Noradrenaline levels (Tables i and 2 , Fig. 4 ) rose significantly during morning hypoglycaemia on each study day (p < 0.05). During the control week, compared to the response on Day1, no significant change in the noradrenaline response to morning hypoglycaemia was seen on Day 3 or Day 8. During the hypo week compared to Day I no change was seen in the response on Day 3 or Day 8. (Tables i and 2 , Fig. 6 ) rose during morning hypoglycaemia on each study day (p <0.05). However, the response did not change significantly on Day 3 or Day 8 compared to Day 1 in either study week.
Blood pressure and heart rate. Systolic pressure rose significantly during hypoglycaemia on Day 8 of hypo week only (data not shown).
No significant change in diastolic pressure was seen during hypoglycaemia on any study day in either study week (data not shown).
Heart rate rose significantly during hypoglycaemia on Days1 (p<0.001), 3 (p<0.03) and Day8 (p < 0.01) of hypo week and Day i (p < 0.01) of the control week (data not shown).
Symptom scores. Total symptom scores (Tables i and  2 , Fig.7 ) rose during hypoglycaemia on each study day (p < 0.05 on all days). No significant change in the this response was seen between days in the control week. In hypo week, compared to Day i the response on Day 3 was attenuated (p < 0.03), but not (Tables 1  and 2 ) followed a similar pattern with attenuated rise on Day 3 compared to Day 1 of hypo week but not on Day 8.
Neuroglycopenic symptom scores (Tables 1 and 2 ) rose significantly only on Day 8 of hypo week. No significant changes in scores during hypoglycaemia were seen between study days in either study week.
None of the responses on Day i of hypo and control weeks were significantly different.
Discussion
Our data confirm previous studies in diabetic and normal subjects which have reported impairments in the symptomatic and counterregulatory hypoglycaemic response following antecedent hypoglycaemia [13] [14] [15] [22] [23] [24] . We have also measured pcripheral physiological responses which allowed us to explore whether a reduced symptomatic response was either a consequence of diminished sympathoadrenal activation or a failure of subjects to recognise peripheral changes. The responses most affected by hypoglycaemia were those of adrenaline and sweating which were impaired 2 days after the initial hypoglycaemic episode and were still reduced after a week. However, we cannot be certain that the effect of antecedent hypoglycaemia lasts a full 7 days. A consequence of our study design was that the morning hypoglycaemic clamps used to test the physiology may themselves have affected the response they were measuring. Widom and Simonson [23] have shown that 1-h periods of hypoglycaemia, repeated over 4 days produce an impaired counterregulatory and symptomatic response to subsequent hypoglycaemia. Thus, even the brief 30 min of hypoglycaemia on days i and 3 may have a cumulative effect in addition to the 2 h of hypoglycaemia on the afternoon of Day 1. Nevertheless, since there was a 5-day gap before the response was tested again on Day 8, we can conclude that sweating and adrenaline responses to subsequent hypoglycaemia remain impaired for at least 5 days following antecedent hypoglycaemia. The data show that not all responses were affected equally. Measurements of tremor were unaffected by antecedent hypoglycaemia with similar responses recorded on each occasion they were tested. This could be because our method of recording tremor was not sufficiently sensitive to identify minor changes. However, since the equipment consistently recorded a significant increase during each period of hypoglycaemia we would expect it to detect an impaired response. Thus, there may be a differential effect of antecedent hypoglycaemia on the hypoglycaemic physiological response. Sweating is mediated by sympathetic cholinergic fibres [25] while the tremor response is caused both by activation of sympathetic noradrenergic fibres and also by increases in circulating adrenaline [25] . The individual components of the physiological response to hypoglycaemia are activated at different glucose levels [26] and it is conceivable that some may be less affected by the depth or duration of antecedent hypoglycaemia than others. Alternatively, peripheral physiological responses may be equally impaired following hypoglycaemia but the rate at which various responses recover might differ.
The changes we observed in adrenaline and noradrenaline also support the notion of a differential response. Both adrenaline and noradrenaline concentrations normally increase during hypoglycaemia although the magnitude of the adrenaline response is disproportionately greater [27] . We found that although the adrenaline responses to hypoglycaemia were attenuated following antecedent hypoglycaemia at both Days 3 and 8, those of noradrenaline were unaffected. The increase in adrenaline during hypoglycaemia is secondary to adrenomedullary secretion activated centrally while increases in plasma noradrenaline probably reflect increased peripheral sympathetic activity and spillover from post-ganglionic neurons [27] . Hoffman et al. [28] have recently reported a dissociation between muscle sympathetic nerve activity and increases in adrenaline during hypoglycaemia and suggested that the responses may be independently mediated. It is of interest that the hypoglycaemic tremor response, which is in part mediated through activation of sympathetic noradrenergic neurons [25] was not significantly attenuated following antecedent hypoglycaemia while other components of the physiological response (such as sweating) mediated through other mechanisms were impaired.
The possibility of a differential recovery of impaired physiological responses to hypoglycaemia is supported by data from a recent study by DagogoJack et al. [29] . They report a restoration in the symptomatic response to hypoglycaemia among patients with IDDM who avoided hypoglycaemia for 3 months although the counterregulatory response remained unchanged. Clearly, further work is necessary to confirm whether antecedent hypoglycaemia causes differential impairments in the physiological response to subsequent hypoglycaemia.
Why should 2 h of hypoglycaemia modify responses for up to a week? Data from animal models have suggested possible mechanisms whereby cerebral tissue could adapt to repeated episodes of hypoglycaemia. Increased cerebral glucose utilisation has been demonstrated in rats rendered chronically hypoglycaemic [30] and attributed to increased numbers of glucose transporters or increased cerebral blood flow [31] . However, hypoglycaemia had to be maintained for weeks to demonstrate an effect, considerably longer than in our study. Boyle et al. [32] have recently shown that 56 h of mild hypoglycaemia increases brain glucose uptake in non-diabetic humans, which is maintained when blood glucose is lowered and this adaptation could explain the diminished responses we observed. Nevertheless, 56 h is still far longer than the 2 h of hypoglycaemia we induced in our study and there has been no demonstration of changes in cerebral glucose utilisation or transport following brief hypoglycaemic episodes. Thus, the mechanisms which underly the prolonged alteration in response following short-term hypoglycaemia remain unknown.
In summary, we have demonstrated in non-diabetic subjects that while some components of the physiological response to hypoglycaemia are attenuated for at least 5 days following 2 h of hypoglycaemia, others are apparently unaffected. A differential response to antecedent hypoglycaemia may offer clues to its pathogenesis and suggest clinical approaches to mitigate its effect among those with diabetes.
